We recently demonstrated [3] a novel function of the OVOL1 (ovo-like 1, Entrez GeneID 5017) and OVOL2 (ovo-like 2, GeneID 58495) TFs as critical inducers of MET in prostate cancer. The gene discussed is OVOL1; the disease is prostate carcinoma.